Martijn J H Tjan - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Frontiers in Public Health|January 19, 2024

Academic medical centres in the Netherlands: muddling through or radical change?Ester M M Cardinaal, Martijn J H Tjan, Patrick P T Jeurissen, et al.

Frontiers in Immunology|July 12, 2023

Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinibMark W D Sweep, Martijn J H Tjan, Mark A J Gorris, et al.

Frontiers in Cellular and Infection Microbiology|November 12, 2019

Drug Discovery and Repurposing Inhibits a Major Gut Pathogen-Derived Oncogenic ToxinPaul Metz, Martijn J H Tjan, Shaoguang Wu, et al.

Cancers|September 9, 2022

Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer PatientsGerben Lassche, Sjoerd van Helvert, Astrid Eijkelenboom, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Frontiers in Public Health|January 19, 2024

Academic medical centres in the Netherlands: muddling through or radical change?Ester M M Cardinaal, Martijn J H Tjan, Patrick P T Jeurissen, et al.

Frontiers in Immunology|July 12, 2023

Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinibMark W D Sweep, Martijn J H Tjan, Mark A J Gorris, et al.

Frontiers in Cellular and Infection Microbiology|November 12, 2019

Drug Discovery and Repurposing Inhibits a Major Gut Pathogen-Derived Oncogenic ToxinPaul Metz, Martijn J H Tjan, Shaoguang Wu, et al.

Cancers|September 9, 2022

Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer PatientsGerben Lassche, Sjoerd van Helvert, Astrid Eijkelenboom, et al.

Pageof 1